Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Dermatologic 1

Conditions

Colorectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pancreatitis, Chronic 1Pancreatic Neoplasms 1Pain 1Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphedema 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leiomyoma 1Keratosis, Actinic 1Hodgkin Disease 1Dermatitis, Contact 1Dendritic Cell Sarcoma, Interdigitating 1Chalazion 1Carcinoma, Basal Cell 1Burkitt Lymphoma 1Breast Neoplasms 1Breast Cancer Lymphedema 1Anemia, Refractory, with Excess of Blasts 1Adenomyosis 1

Interventions

Aminolevulinic Acid 18Fluorouracil 17Photochemotherapy 15Imiquimod 11Cryotherapy 93-ingenyl angelate 9methyl 5-aminolevulinate 8calcipotriene 5Radiotherapy 4Prilocaine 4Petrolatum 4Lidocaine 4tirbanibulin 3Niacinamide 3Tomography, Optical Coherence 2Therapeutics 2Solutions 2Phototherapy 2Gels 2Diclofenac 2Cryosurgery 2Celecoxib 2Blue Light 2Biopsy 21-phenyl-3,3-dimethyltriazene 2tazarotene 1perillyl alcohol 1dexpanthenol 1dehydroftorafur 1cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Keratosis, Actinic × Triamcinolone × Clear all
NCT00021294 2018-09-11

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

University of Arizona

Phase 2 Completed
DermatologicOther neoplasm

Carcinoma, Basal Cell, Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡